2C-B-aminorex

2C-B-aminorex
Clinical data
Other names	2C-B-AR
Legal status
Legal status	In general Unscheduled;
Identifiers
	IUPAC name 5-(4-bromo-2,5-dimethoxyphenyl)-4,5-dihydro-1,3-oxazol-2-amine;
PubChem CID	165360199;
ChemSpider	129433828;
UNII	HBY9BQ3YJK;
CompTox Dashboard (EPA)	DTXSID901336883 ;
Chemical and physical data
Formula	C11H13BrN2O3
Molar mass	301.140 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES COC1=CC(=C(C=C1C2CN=C(O2)N)OC)Br;
	InChI InChI=1S/C11H13BrN2O3/c1-15-8-4-7(12)9(16-2)3-6(8)10-5-14-11(13)17-10/h3-4,10H,5H2,1-2H3,(H2,13,14)/t10-/m0/s1; Key:XUTCHZHTIDHQOP-JTQLQIEISA-N;

2C-B-aminorex (2C-B-AR) is a recreational designer drug with psychedelic and/or stimulant effects.^[1] It is a substituted aminorex derivative which was first identified in Sweden in June 2019.^[2]^[1] Structurally, it is a hybrid of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) and aminorex.^[3]^[1]

References

1 2 3 "2C-B-AR (2C-B aminorex)". АИПСИН (in Russian). Retrieved 1 January 2026.
↑ Evans-Brown M, Gallegos A, Christie R, Jorge R, De Morais J, Almeida A, et al. (December 2020). New Psychoactive Substances: Global Markets, Glocal Threats and the COVID-19 Pandemic. An update from the EU Early Warning System (PDF). European Monitoring Centre for Drugs and Drug Addiction. Luxembourg: Publications Office of the European Union. doi:10.2810/921262. ISBN 978-92-9497-557-7.
↑ Seibert E, Kunert O, Pferschy-Wenzig EM, Schmid MG (September 2022). "Characterization of Three Novel 4-Methylaminorex Derivatives Applied as Designer Drugs". Molecules. 27 (18): 5770. doi:10.3390/molecules27185770. PMC 9503756. PMID 36144500.

This hallucinogen-related article is a stub. You can help Wikipedia by adding missing information.